Janus Henderson Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Janus Henderson Group’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-391,264	Closed	-$2.61M	–	2630
2023 Q3	$2.61M	Buy	391,264 +99,548	+34%	+$827K	﹤0.01%	1054
2023 Q2	$2.64M	Buy	291,716 +262,162	+887%	+$2.31M	﹤0.01%	1100
2023 Q1	$215K	Buy	29,554 +15,616	+112%	+$116K	﹤0.01%	2458
2022 Q4	$102K	Buy	+13,938	New	+$103K	﹤0.01%	2326
2021 Q2	–	Sell	-97,282	Closed	-$1.03M	–	1689
2021 Q1	$1.03M	Sell	97,282 -26,425	-21%	-$358K	﹤0.01%	1266
2020 Q4	$1.73M	Sell	123,707 -959	-0.8%	-$13.3K	﹤0.01%	1141
2020 Q3	$1.79M	Buy	+124,666	New	+$1.7M	﹤0.01%	1070

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Janus Henderson Group's PNT Position: Q4 2023 in Review

Janus Henderson Group sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 391,264 shares — an estimated $2.61M sold.

Janus Henderson Group first reported a position in PNT in Q3 2020 and held it in 7 quarters. The position peaked at $2.64M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Janus Henderson Group reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Janus Henderson Group sold 391,264 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $2.61M.
Janus Henderson Group first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Janus Henderson Group's POINT Biopharma Global Inc. Common Stock position peaked at $2.64M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.